RP60556A

Class: Benzo[b]naphthyridone

Spectrum of activity:	Gram-negative
Details of activity:	Topical treatment
Institute where first reported:	Aventis (Sanofi-Aventis, France)
Year first mentioned:	2000
Highest developmental phase:	Preclinical
Development status:	Inactive

Chemical structure(s):
Canonical SMILES:	CN1C=C(C(=O)C2=CC3=C(C=C(C(=C3)F)N4CCN(CC4)C5=CC=C(C=C5)F)N=C21)C(=O)O
Isomeric SMILES:	CN1C=C(C(=O)C2=C1N=C3C=C(C(=CC3=C2)F)N4CCN(CC4)C5=CC=C(C=C5)F)C(=O)O
InChI:	InChI=1S/C24H20F2N4O3/c1-28-13-18(24(32)33)22(31)17-10-14-11-19(26)21(12-20(14)27-23(17)28)30-8-6-29(7-9-30)16-4-2-15(25)3-5-16/h2-5,10-13H,6-9H2,1H3,(H,32,33)
InChI Key:	YYHFVZLNDMSUBV-UHFFFAOYSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/484065

External links:
Guide to Pharmacology:	RP60556A
Main Source:	https://www.sciencedirect.com/science/article/pii/S0960894X01000919?via%3Dihub